MADRIGAL PHARMACEUTICALS, INC. (MDGL) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-18

MADRIGAL PHARMACEUTICALS, INC. (MDGL) has filed 9 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-18. 3 Form 8-K material event filings were reported by MDGL in the last 90 days. 3 Form 144 notices of proposed sale were filed for MDGL stock. InsiderAlpha tracks every MDGL SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About MADRIGAL PHARMACEUTICALS, INC. (MDGL)

SEC CIK0001157601

90-Day SEC Filing Activity

Form 4 filings (90d)9
Form 8-K filings (90d)3
Form 144 notices (90d)3
Latest Form 4 filing2026-06-18

Recent MDGL Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Levy Richard SDirectorA — Grant or award454$0.00—SEC
BAKER BROS. ADVISORS LPInsiderA — Grant or award908$0.00—SEC
FOUSE JACQUALYN ADirectorA — Grant or award454$0.00—SEC
Taub RebeccaDirectorA — Grant or award454$0.00—SEC
Daly James MDirectorA — Grant or award454$0.00—SEC
Brennan Daniel J.DirectorA — Grant or award404$0.00—SEC
BAKER BROS. ADVISORS LPInsiderA — Grant or award908$0.00—SEC
Soergel DavidChief Medical OfficerS — Open-market sale1.0K$495.74$517KSEC
Levy Richard SDirectorS — Open-market sale80$519.98$42KSEC
Levy Richard SDirectorS — Open-market sale343$514.67$177KSEC
Levy Richard SDirectorS — Open-market sale723$516.87$374KSEC
Levy Richard SDirectorS — Open-market sale657$515.92$339KSEC
Levy Richard SDirectorS — Open-market sale1.5K$517.59$775KSEC
Levy Richard SDirectorS — Open-market sale782$518.76$406KSEC
Levy Richard SDirectorS — Open-market sale610$511.40$312KSEC

All transactions sourced from SEC EDGAR Form 4 filings for MADRIGAL PHARMACEUTICALS, INC. (MDGL). Updated in real time as new filings are submitted to the SEC.

Most-Active MDGL Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
Levy Richard S14$2.93M
BAKER BROS. ADVISORS LP4—
Taub Rebecca2—
Soergel David2$952K
FOUSE JACQUALYN A2—

Recent MDGL Form 8-K Material Events

Recent MDGL Form 144 Notices of Proposed Sale

Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in MDGL insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

MDGL Insider Trading — FAQ

What is the latest insider trade for MDGL?
MADRIGAL PHARMACEUTICALS, INC. (MDGL) had 9 insider filings in the last 90 days, with the most recent on 2026-06-18. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying MDGL stock?
0 insider purchases of MDGL were filed in the last 90 days.
How many insiders are selling MDGL stock?
0 insider sales of MDGL were filed in the last 90 days.
Where can I see MDGL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every MDGL SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live MDGL dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.